Phillip G. Durham

lampe joint department of biomedical engineering, university of north carolina and north carolina state university, chapel hill, nc, usa

H指数:14

被引数:713

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In Vivo Performance of Airway and Lung Ultrasound Enhanced via Inhalable Contrast Agents

吸入性造影剂增强的气道和肺超声的体内性能

Ultrasonic Imaging

IF2.5

2025-11-010

PRE

Development of an inhalable contrast agent targeting the respiratory tract mucus layer for pulmonary ultrasonic imaging

SCIENTIFIC REPORTS

IF3.9

2024-12-010

OAAI

Current clinical investigations of focused ultrasound blood-brain barrier disruption: A review

聚焦超声血脑屏障破坏的临床研究进展

NEUROTHERAPEUTICS

IF6.9

2024-04-014

OAAI

Noninvasive measurement of murine glioblastoma in vivo with a benchtop ultrasound instrument

CANCER RESEARCH

IF16.6

2024-03-220

PRE

The Pharmacokinetics of CPZEN-45, a Novel Anti-Tuberculosis Drug, in Guinea Pigs

PHARMACEUTICS

IF5.5

2023-12-121

OAAI

Nanoparticle-Epoxy Composite Molding for Undeformed Acoustic Holograms With Tailored Acoustic Properties

纳米粒子-环氧复合材料成型，用于具有定制声学特性的未变形声全息图

IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL

IF3.7

2023-11-014

PRE

Overcoming biological barriers to improve treatment of a Staphylococcus aureus wound infection

克服生物学障碍以改善金黄色葡萄球菌伤口感染的治疗

CELL CHEMICAL BIOLOGY

IF7.2

2023-05-0114

OAAI

Optimization and Scale Up of Spray Dried CPZEN-45 Aerosol Powders for Inhaled Tuberculosis Treatment

PHARMACEUTICAL RESEARCH

IF4.3

2022-09-166

OAAI

Harnessing ultrasound-stimulated phase change contrast agents to improve antibiotic efficacy against methicillin-resistant Staphylococcus aureus biofilms

BIOFILM

IF4.9

2021-12-0123

OAAI

Applications of sub-micron low-boiling point phase change contrast agents for ultrasound imaging and therapy

CURRENT OPINION IN COLLOID & INTERFACE SCIENCE

IF7

2021-12-0124

PRE

Acoustic holograms for directing arbitrary cavitation patterns

APPLIED PHYSICS LETTERS

IF3.6

2021-02-0233

PREAI

A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis Therapy

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2019-10-0120

OAAI

Inorganic nanoparticles and the microbiome

无机纳米粒子和微生物组

NANO RESEARCH

IF9

2018-07-1351

OAAI

A dry powder combination of pyrazinoic acid and its n-propyl ester for aerosol administration to animals

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2016-12-0111

OAAI

Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis

PHARMACEUTICAL RESEARCH

IF4.3

2016-06-287

PREAI

In vitro dry powder inhaler formulation performance considerations

JOURNAL OF CONTROLLED RELEASE

IF11.5

2015-02-0116

PREAI

The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy

颗粒理化性质在结核病治疗的肺部药物递送中的作用

JOURNAL OF MICROENCAPSULATION

IF3.2

2014-08-0442

PREAI

Phillip G. Durham

个人简介

教育背景

工作经历

荣誉奖项

研究方向